I copied this old post from the rapamycin group. The original post can be found here: facebook.com/share/p/1BrkDZXAQb
IL-11 is an inflammatory molecule produced in excess by our immune systems as we get older. It has been linked to numerous diseases, including heart disease. Blocking it dramatically extends lifespan in mice.
—————-
This is a graph that’s been circulating on Twitter. It shows how blocking IL-11 compares to other aging interventions in mice.
Not only is the percentage median life extension from IL-11 inhibition very large, but it sets new records in terms of absolute median lifespan. The mice in this paper were living almost 1100 days on average, which beats pretty much everything (not counting genetic manipulations).
What I really love about this IL-11 intervention is that it appears to be very low hanging fruit. We don’t know much about IL-11, but we do know a heck of a lot about IL-6. And we know that IL-11 is in the IL-6 family of cytokines.
This family of IL-6 cytokines can easily be reduced by diet, exercise, lifestyle, supplements, and drugs. There are dozens of plant-derived molecules that can reduce this IL-6 family of cytokines. And there are safe drugs with already-proven benefits that can do it as well (e.g. statins, aspirin, metformin, ACE inhibitors, etc.).
It’s also worth noting that the heart disease drug colchicine might work, in part, by inhibiting IL-11. But this is speculative. See this post: ↪ Colchicine may work partly by inhibiting IL-11, a lifespan-linked pro-fibrotic cytokine.
Reference:
I think the original graph in this post comes from Matt Kaeberlein. Somebody modified it to add the new IL-11 intervention at the bottom.
trials.”
#il11HD #agingHD #longevityHD #inflammationHD #il6HD #senolyticsHD #akgHD #rapamycinHD #metforminHD #nrHD #calorierestrictionHD #fastingHD #miceHD



